If you live in the United States, odds are high that a tiny passenger rides in your blood. By adulthood, more than 94 percent ...

One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic ...

Using a single-cell RNA-sequencing platform, a new study demonstrates that EBV reprograms autoreactive B cells to drive lupus autoimmunity.

It has been thought that in the first step in B cell activation, when these immune cells recognize an infectious pathogen, an antigen from that pathogen had to bind to multiple receptors on the ...

Barr virus transforms B cells into inflammatory drivers that spark the widespread immune attacks seen in lupus.

In vitro studies have suggested that BTKi therapy can suppress NOTCH1 activation via B-cell receptor–NOTCH1 interactions, providing a mechanistic rationale for these clinical results.

The combination of glofitamab (Columvi) plus polatzumab vedotin (Polivy) demonstrated high efficacy and durable responses in patients with relapsed/refractory large B-cell lymphoma (LBCL), according ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...